Lassa virus infection in experimentally infected marmosets: Liver pathology and immunophenotypic alterations in target tissues

Journal of Virology

Volumn 81, Issue 12, 2007, Pages 6482-6490

  Carrion Jr , Ricardo ^a   Brasky, Kathleen ^b   Mansfield, Keith ^c   Johnson, Curtis ^a   Gonzales, Monica ^a   Ticer, Anysha ^a   Lukashevich, Igor ^d   Tardif, Suzette ^b,e   Patterson, Jean ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUTE OF HUMAN VIROLOGY   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; LIVER ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS RNA;

ADAPTIVE IMMUNITY; ADOLESCENT; AFRICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL AGGREGATION; CELL PROLIFERATION; CONTROLLED STUDY; FEVER; HISTOPATHOLOGY; IMMUNOPHENOTYPING; INTERSTITIAL NEPHRITIS; LASSA FEVER; LASSA VIRUS; LIVER CELL; LIVER DISEASE; LIVER NECROSIS; LYMPH FOLLICLE; MACROPHAGE; MARMOSET; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; WEIGHT REDUCTION;

ANIMALS; ANTIGENS, CD20; ANTIGENS, CD3; CALLITHRIX; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; LASSA FEVER; LASSA VIRUS; LIVER; LYMPHOCYTES; TIME FACTORS;

CALLITHRIX JACCHUS; LASSA VIRUS; LASSA VIRUS JOSIAH; PRIMATES;

EID: 34249952426     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02876-06     Document Type: Article

References (50)

1. Asper, M., P. Hofmann, C. Osmann, J. Funk, C. Metzger, M. Bruns, F. J. Kaup, H. Schmitz, and S. Gunther. 2001. First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. Virology 284:203-213.
2. Auperin, D. D., J. J. Esposito, J. V. Lange, S. P. Bauer, J. Knight, D. R. Sasso, and J. B. McCormick. 1988. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res. 9:233-248.
3. Avila, M., S. R. Samoilovich, R. P. Laguens, M. S. Merani, and M. C. Weissenbacher. 1987. Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J. Med. Virol. 21:67-74.
4. Baize, S., D. Pannetier, C. Faure, P. Marianneau, I. Marendat, M. C. Georges-Courbot, and V. Deubel. 2006. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect. 8:1194-1202.
5. Baize, S., J. Kaplon, C. Faure, D. Pannetier, M. C. Georges-Courbot, and V. Deubel. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172:2861-2869.
6. Borio, L., T. Inglesby, C. J. Peters, A. L. Schmaljohn, J. M. Hughes, P. B. Jahrling, T. Ksiazek, K. M. Johnson, A. Meyerhoff, T. O'Toole, M. S. Ascher, J. Bartlett, J. G. Breman, E. M. Eitzen, Jr., M. Hamburg, J. Hauer, D. A. Henderson, R. T. Johnson, G. Kwik, M. Layton, S. Lillibridge, G. J. Nabel, M. T. Osterholm, T. M. Perl, P. Russell, and K. Tonat for the Working Group on Civilian Biodefense. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405.
7. Bredenbeek, P. J., R. Molenkamp, W. J. Spaan, V. Deubel, P. Marianneau, M. S. Salvato, D. Moshkoff, J. Zapata, I. Tikhonov, J. Patterson, R. Carrion, A. Ticer, K. Brasky, and I. S. Lukashevich. 2006. A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins. Virology 345:299-304.
8. Callis, R. T., P. B. Jahrling, and A. DePaoli. 1982. Pathology of Lassa virus infection in the rhesus monkey. Am. J. Trop. Med. Hyg. 31:1038-1045.
9. Carrion, R., Jr., et al. 27 February 2007, posting date. A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine. doi:10.1016/j.vaccine.2007.02.038.
10. Clegg, J. C., and G. Lloyd. 1987. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea pigs against Lassa fever. Lancet ii:186-188.
11. Davern, T., and B. F. Scharschmidt. 1998. Biochemical liver tests, p. 345-367. In M. Feldman, B. F. Scharschmidt, and M. H. Sleisenger (ed.), Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. Saunders, Philadelphia, PA.
12. Demby, A. H., J. Chamberlain, D. W. Brown, and C. S. Clegg. 1994. Early diagnosis of Lassa fever by reverse transcription-PCR. J. Clin. Microbiol. 32:2898-2903.
13. Fisher-Hoch, S. P., L. Hutwagner, B. Brown, and J. B. McCormick. 2000. Effective vaccine for Lassa fever. J. Virol. 74:6777-6783.
14. Fisher-Hoch, S. P., and J. B. McCormick. 2004. Lassa fever vaccine. Expert Rev. Vaccines 3:189-197.
15. González, P. H., R. P. Laguens, M. J. Frigerio, M. A. Calello, and M. C. Weissenbacher. 1983. Junin virus infection of Callithrix jacchus: pathologic features. Am. J. Trop. Med. Hyg. 32:417-423.
16. Greenough, T. C., A. Carville, J. Coderre, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, and K. Mansfield. 2005. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am. J. Pathol. 167:455-463.
17. Jacob, J. R., K. C. Lin, B. C. Tennant, and K. G. Mansfield. 2004. GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J. Gen. Virol. 85:2525-2533.
18. Jahrling, P. B., R. A. Hesse, G. A. Eddy, K. M. Johnson, R. T. Callis, and E. L. Stephen. 1980. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141:580-589.
19. Jahrling, P. B., S. Smith, R. A. Hesse, and J. B. Rhoderick. 1982. Pathogenesis of Lassa virus infection in guinea pigs. Infect. Immun. 37:771-778.
20. Ludlage, E., C. L. Murphy, S. M. Davern, A. Solomon, D. T. Weiss, D. Glenn-Smith, S. Dworkin, and K. G. Mansfield. 2005. Systemic AA amyloidosis in the common marmoset. Vet. Pathol. 42:117-124.
21. Lukashevich, I. S. 1987. Human pathogens of the Arenaviridae family. Sov. Med. Rev. E 2:133-186.
22. Lukashevich, I. S. 1985. Lassa virus lethality for inbred mice. Ann. Soc. Belg. Med. Trop. 65:207-209.
23. Lukashevich, I. S., I. Tikhonov, J. D. Rodas, J. C. Zapata, Y. Yang, M. Djavani, and M. S. Salvato. 2003. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol. 77:1727-1737.
24. Lukashevich, I. S., J. D. Rodas, I. I. Tikhonov, J. C. Zapata, Y. Yang, M. Djavani, and M. S. Salvato. 2004. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration. Arch. Virol. 149:2319-2336.
25. Lukashevich, I. S., J. D. Rodas, I. Tikhonov, J. C. Zapata, Y. Yang, M. Djavani, and M. S. Salvato. 2003. Arenavirus-mediated liver pathology in rhesus macaques, p. 490-491. In Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease. International Medical Press Ltd., Sydney, Australia.
26. Lukashevich, I. S., J. Patterson, R. Carrion, D. Moshkoff, A. Ticer, J. Zapata, K. Brasky, R. Geiger, G. H. Hubbard, J. Bryant, and M. S. Salvato. 2005. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J. Virol. 79:13934-13942.
27. Lukashevich, I. S., R. Maryankova, A. S. Vladyko, N. Nashkevich, S. Koleda, M. Djavani, D. Horejsh, N. Voitenok, and M. S. Salvato. 1999. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-α gene expression. J. Med. Virol. 59:552-560.
28. Macher, A. M., and M. S. Wolfe. 2006. Historical Lassa fevers reports and 30-year clinical update. Emerg. Infect. Dis. 12:835-837.
29. Mahanty, S., D. G. Bausch, R. L. Thomas, A. Goba, A. Bah, C. J. Peters, and P. E. Rollin. 2001. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183:1713-1721.
30. Mahanty, S., K. Hutchinson, S. Agarwal, M. McRae, P. E. Rollin, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801.
31. Mansfield, K. 2003. Marmoset models commonly used in biomedical research. Comp. Med. 53:383-392.
32. McCormick, J. B., P. A. Webb, J. W. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
33. McCormick, J. B., D. H. Walker, I. J. King, P. A. Webb, L. H. Elliott, S. G. Whitfield, and K. M. Johnson. 1986. Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am. J. Trop. Med. Hyg. 35:401-407.
34. McCormick, J. B., and S. P. Fisher-Hoch. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
35. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
36. Montali, R. J., B. M. Connolly, D. L. Armstrong, C. A. Scanga, and K. V. Holmes. 1995. Pathology and immunohistochemistry of callitrichid hepatitis, an emerging disease of captive New World primates caused by lymphocytic choriomeningitis virus. Am. J. Pathol. 147:1441-1449.
37. Montali, R. J., C. A. Scanga, D. Pernikoff, D. R. Wessner, R. Ward, and K. V. Holmes. 1993. A common-source outbreak of callitrichid hepatitis in captive tamarins and marmosets. J. Infect. Dis. 167:946-950.
38. Oldstone, M. B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263:83-117.
39. Patterson, J. L., and R. Carrion, Jr. 2005. Demand for nonhuman primate resources in the age of biodefense. ILAR J. 46:15-22.
40. Peters, C. J., P. B. Jahrling, C. T. Liu, R. H. Kenyon, K. T. McKee, Jr., and J. G. Barrera Oro. 1987. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134:5-68.
41. Pushko, P., J. Geisbert, M. Parker, P. Jahrling, and J. Smith. 2001. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J. Virol. 75:11677-11685.
42. Salvato, M. S., J. C. S. Clegg, M. J. Buchmeier, R. N. Charrel, J.-P. Gonzalez, I. S. Lukashevich, C. J. Peters, R. Rico-Hesse, and V. Romanowski. 2005. Arenaviridae, p. 725-733. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy, VIIIth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, London, United Kingdom.
43. Stephensen, C. B., J. Y. Park, and S. R. Blount. 1995. cDNA sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus. J. Virol. 69:1349-1352.
44. Tandon, B. N., and S. K. Acharya. 1987. Viral diseases involving the liver. Bailliere's Clin. Gastroenterol. 1:211-230.
45. Walker, D. H., J. B. McCormick, K. M. Johnson, P. A. Webb, G. Komba-Kono, L. H. Elliott, and J. J. Gardner. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107:349-356.
46. Walker, D. H., H. Wulff, J. V. Lange, and F. A. Murphy. 1975. Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull. W. H. O. 52:523-534.
47. Walker, D. H., K. M. Johnson, J. V. Lange, J. J. Gardner, M. P. Kiley, and J. B. McCormick. 1982. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J. Infect. Dis. 146:360-368.
48. Weissenbacher, M. C., C. E. Coto, M. A. Calello, S. N. Rondinone, E. B. Damonte, and M. J. Frigerio. 1982. Cross-protection in nonhuman primates against Argentine hemorrhagic fever. Infect. Immun. 35:425-430.
49. Weissenbacher, M. C., M. A. Calello, M. S. Merani, J. B. McCormick, and M. Rodriguez. 1986. Therapeutic effect of the antiviral agent ribavirin in Junin virus infection of primates. J. Med. Virol. 20:261-267.
50. Winn, W. C., Jr., T. P. Monath, F. A. Murphy, and S. G. Whitfield. 1975. Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. Arch. Pathol. 99:599-604.